| 51 |
8720415 | Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients. | 1996 Feb |
1 |
| 52 |
8797128 | Fosinopril versus enalapril in the treatment of hypertension: a double-blind study in 195 patients. | 1996 Jul |
1 |
| 53 |
8861547 | Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension. | 1996 May |
2 |
| 54 |
8931831 | Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy. | 1996 Nov |
1 |
| 55 |
8934359 | The angiotensin converting enzyme inhibitors fosinopril and enalapril differ in their central nervous effects in humans. | 1996 Nov |
3 |
| 56 |
8934382 | Trials investigating the anti-atherosclerotic effects of antihypertensive drugs. | 1996 Sep |
1 |
| 57 |
7658352 | Aggregation behavior of fosinopril sodium--a new angiotensin-converting enzyme inhibitor. | 1995 May |
3 |
| 58 |
7751424 | Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment. | 1995 Feb |
2 |
| 59 |
7752642 | Regression of early atherosclerosis in hyperlipidemic hamsters induced by fosinopril and captopril. | 1995 Feb |
3 |
| 60 |
7771972 | Critical assessment of ACE inhibitors. Part 2. | 1995 Apr |
1 |
| 61 |
11854791 | A Comparison of the Cough Profile of Fosinopril and Enalapril in Hypertensive Patients with a History of ACE Inhibitor-Associated Cough. | 1995 Oct |
1 |
| 62 |
7528851 | Antiatherosclerotic effects of the angiotensin-converting enzyme inhibitors captopril and fosinopril in hypercholesterolemic minipigs. | 1994 Oct |
1 |
| 63 |
7882821 | Effect of fosinopril on cardiac and metabolic parameters in patients with NIDDM. | 1994 Dec |
3 |
| 64 |
7919557 | Cough induced by quinapril with resolution after changing to fosinopril. | 1994 Jun |
5 |
| 65 |
7957538 | Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition. | 1994 |
2 |
| 66 |
7980708 | Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. | 1994 Jul |
1 |
| 67 |
7986469 | Unchanged neurogenic vasoconstrictor response after exercise during angiotensin converting enzyme inhibition with fosinopril. | 1994 Aug |
1 |
| 68 |
8052432 | ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study. | 1994 |
1 |
| 69 |
8281674 | Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty. | 1994 Jan |
2 |
| 70 |
8285179 | Angiotensin-converting enzyme inhibitors: more different than alike? Focus on cardiac performance. | 1993 Dec 30 |
1 |
| 71 |
8285181 | Metabolic effects of converting enzyme inhibitors: focus on the reduction of cholesterol and lipoprotein(a) by fosinopril. | 1993 Dec 30 |
1 |
| 72 |
8285182 | Safety update: focus on cough. | 1993 Dec 30 |
2 |
| 73 |
1283426 | Kinetics of angiotensin-converting enzyme inhibitors in renal failure. | 1992 |
1 |
| 74 |
1283427 | Left ventricular hypertrophy and performance: therapeutic options among the angiotensin-converting enzyme inhibitors. | 1992 |
1 |
| 75 |
1283429 | Fosinopril: a new generation of angiotensin-converting enzyme inhibitors. | 1992 |
4 |
| 76 |
1318861 | In vitro stability of the inhibition of serum converting enzyme by fosinopril. | 1992 |
1 |
| 77 |
1372856 | Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension. | 1992 Jan |
3 |
| 78 |
1533588 | Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril. | 1992 |
3 |
| 79 |
1534664 | Effects of fosinopril on cardiac function in patients with hypertension. Radionuclide assessment of left ventricular systolic and diastolic performance. | 1992 Apr |
2 |
| 80 |
1646240 | Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects. | 1991 Jan |
3 |
| 81 |
1652404 | Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency. | 1991 May |
2 |
| 82 |
1826651 | Pharmacokinetics of fosinopril in patients with various degrees of renal function. | 1991 Apr |
2 |
| 83 |
1834450 | Fosinopril (Staril)--another ACE inhibitor. | 1991 Jun 10 |
2 |
| 84 |
1835932 | Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients. | 1991 |
1 |
| 85 |
2142429 | The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension. | 1990 Jun |
1 |
| 86 |
2148357 | Fosinopril prevents hyperfiltration and decreases proteinuria in post-transplant hypertensives. | 1990 Nov |
1 |
| 87 |
2207707 | The ACE inhibitor [3H]SQ29,852 identifies a high affinity recognition site located in the human temporal cortex. | 1990 Jul |
1 |
| 88 |
2836111 | Structural relationships of angiotensin converting-enzyme inhibitors to pharmacologic activity. | 1988 Jun |
1 |
| 89 |
2967089 | Disposition of fosinopril sodium in healthy subjects. | 1988 Jan |
2 |
| 90 |
2970855 | Effects of fosenopril, a once-daily angiotensin-converting enzyme inhibitor, on resting and exercise-induced changes of blood pressure, hormonal variables, and plasma potassium in essential hypertension. | 1988 Jul |
3 |